Stay updated on Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no substantive changes to study details are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a Locations section with Washington site details and updated the page revision to v3.3.3. Removed the Washington Locations entry and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check52 days agoChange DetectedPublications section updated to indicate entries are automatically filled from PubMed and may not all reference the study. Revision: v3.3.2.SummaryDifference0.1%

- Check60 days agoChange DetectedThe government funding notice at the top of the page was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedNo significant changes detected between the two screenshots of the Study Details page for NCT03029598. The content and layout appear unchanged.SummaryDifference0.4%

- Check103 days agoChange DetectedUpgrade notice added about funding and operations; version updated to v3.2.0, replacing v3.1.0.SummaryDifference2%

Stay in the know with updates to Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.